Thytech (private company)
See something wrong or missing? Let us know
Offices:Madrid
Industry:BiotechHealth services
Business model:B2B
Thytech is a medical startup from Madrid that is working on a cell therapy to prevent rejection in transplants, autoimmune processes or even mortality in severe COVID patients.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 385.35k
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Thytech
| Name | Criteria | |
|---|---|---|
![]() |
Merozyne Therapeutics
50%
|
|
![]() |
VOC Diagnostics
50%
|
|
![]() |
Valink Therapeutics
50%
|
|
![]() |
Molecular Attraction
50%
|
|
![]() |
StemSight
50%
|
|
![]() |
Aquilón CyL
47%
|
|
![]() |
Bionomous
47%
|
|
![]() |
Celluminova
47%
|
|
![]() |
Cornea Project
47%
|
|
![]() |
Ikan Biotech
47%
|
|





Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal